AmorChem, Institut de Recherches Cliniques de Montreal (IRCM), National Research Council of Canada, Universite de Montreal endocrine/metabolic news

Life science VC fund AmorChem licensed rights to IP co-owned by the council and the university's Univalor commercialization arm relating to single domain antibody technology. AmorChem, along with IRCM...